USANA Health Sciences Inc earnings per share and revenue
On --, USNA reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analysts forecast an EPS of 0.41 USD, with revenue projected to reach 230.48 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were USANA Health Sciences Inc's earnings and revenue for the latest quarter Q-- --?
For Q-- --, USANA Health Sciences Inc reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to USANA Health Sciences Inc's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is USANA Health Sciences Inc expected to report next?
The next earning report is scheduled for Feb 17, 2026.
What are the forecasts for USANA Health Sciences Inc's next earnings report?
Based on 3
analysts, USANA Health Sciences Inc is expected to report EPS of $0.41 and revenue of $230.48M for Q4 2025.